Lena Hagman
About
Lena Hagman is from Greater Gothenburg Metropolitan Area. Lena is currently Executive Vice President Quality Compliance Regulatory and Medical Affairs Getinge AB at Getinge Group, located in Gothenburg, Vastra Gotaland County, Sweden.
You can find Lena Hagman's email address at finalscout.com. FinalScout is a free professional database with over five hundred million business professional profiles and over two hundred million company profiles.
Lena Hagman's current jobs
Experienced business leader within the Medical Device and Life Science Industry. High Business orientation and deep knowledge of company acquisitions and integrations, experience in leading R&D, Operations, Quality, Regulatory and Medical Affairs. Focus areas and strengthens are change management mainly within business processes and efficiency. Extensive knowledge in the European and US Food & Drug Administration (FDA) laws and regulations. Many years’ experience of quality and regulatory remediation programs and multi-site FDA Consent Decree. Ranked as number 7 in The Healthcare Technology Report, “The Top 25 Women Leaders in Medical Devices of 2021”. June 2015 – current Executive Vice President Quality Compliance, Regulatory & Medical Affairs, Getinge AB • Member of Getinge Executive team, reports to President & CEO • Leading a global team, appr. 500 employees • Develop and manage the Quality, Regulatory and Medical Compliance strategy and initiatives. • Monitoring the company remediation program • Move to less notified bodies and implement the new EU-MDR • Develop and implement global quality tools and processes Sept. 2018 – Jan. 2022 Executive Vice President & Managing Director Cardiopulmonary, Getinge (role in parallel with the EVP Quality compliance, Regulatory & Medical Affairs responsibilities) • Member of Getinge Executive team, report to President & CEO • Leading a global team, appr. 1400 employees • Profit & Loss responsibility • Extensive remediation program and production efficiency strategy • Implement lean and efficiency programs to increase production output and profitability • R&D product portfolio pipeline strategy and initiatives